Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Generics - Expanding the Base: Improving Business and Regulatory Predictability for Complex, Niche Generics

Generics - Expanding the Base: Improving Business and Regulatory Predictability for Complex, Niche Generics

Date: Monday, 24 February 2014
Location: Mumbai, India


Keynote Speakers

Ajaz Hussain

Ajaz Hussain
Consultant, Insight Advice & Solutions LLC

Overview

SELECTBIO is organizing an international event “GENERICS AND BIOLOGICS” conference and exhibition on February 24-25, 2014 in Ramada Hotel and Convention Centre, Mumbai, India.

The past decade has witnessed significant consolidation in the generic industry mostly because of patent expiry of large number of pharmaceutical innovator products. Given the tremendous pressure on both innovator and generic companies to maintain growth, this trend is likely to continue. This growth has also brought in stern competition amongst generic pharmaceutical companies in order to get a slice of pie out of the market. Innovation strategies, niche generics, cost reduction and reducing regulatory uncertainties are some of the topics to be deliberated for the success of generic pharmaceutical industry. The Generics track of this event aim to bring together the experience of Pharmaceutical Industry professionals for achieving this objective.

This event is co-located with our 2nd international event on “QbD in Pharma Development” and an exhibition featuring latest technology and equipment in formulation development, bioanalysis and software for QbD studies. Registered delegates will have unrestricted excess to all tracks and exhibition.

Agenda Topics

  • Challenges & Advancements in Complex Generics Formulations
  • Complex and Niche Generics – Market Size and Time to Market
  • Complex Generics-Pricing Pressures & Cost Reduction Strategies for India Drug Industry
  • Contract Manufacturing Landscape for Generics
  • Innovation: Route for Generic Pharma Industry’s Success
  • Reducing Global Regulatory Uncertainty for Complex Generics
  • Scale up of Generics - Learning from Case Studies

Sponsorship and Exhibition Opportunities

Ira Sood, Exhibition Manager
i.sood@selectbio.com
7696225050

Confirmed Speakers to date

Subir Basak, President, Jubilant Life Sciences Limited
Bhupinder Singh Bhoop, Dean, UIPS, Panjab University
Anthony Crasto, Principal Scientist, Glenmark Generics Limited
Vipan Dhall, Vice President & Head, Piramal Pharmaceutical Development Services Pvt Ltd
Ashish Gogia, Vice President, Cadila Pharmaceuticals Limited
Anurag Hitkari, Principal Advisor/Vice President, PragMetis Pharmaserve LLP
Ajaz Hussain, Consultant, Insight Advice & Solutions LLC
Praveen Khullar, Senior Director, Sanofi Aventis Group
Rajashri Ojha, Founder & Director, Raaj Global Pharma Regulatory Affairs Consultants
Harvinder Popli, Managing Director, Zandria Farmaceutica Pvt Ltd
Rajeev Raghuvanshi, Vice President, Dr Reddy's Laboratories Ltd
Mandar Shah, Vice President, Promed Group Ltd.
Venkateswarlu Vobalaboina, Managing Director, Neuheit Pharma Technologies Pvt Ltd


Exhibition Sponsors Media Sponsors Networking
U-Networks

Add to Calendar ▼2014-02-24 00:00:002014-02-24 00:00:00Europe/LondonGenerics - Expanding the Base: Improving Business and Regulatory Predictability for Complex, Niche GenericsSELECTBIOenquiries@selectbiosciences.com